Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Sleep Apnea Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 116 pages | Published: 24-06-2019 |
- Healthcare
- Mordor Intelligence
- 116 pages
- Published: 24-06-2019
Market Overview
The global sleep apnea devices market was valued at USD 5,956.9 million in 2018, and is estimated to be valued at USD 9,193.3 million in 2024, witnessing a CAGR of 7.5%. Few key factors that are driving the market include the increasing incidences of sleep apnea, increasing awareness among the patient population in developing countries, and favorable government initiatives.
According to the Sleep Apnea Organization, in 2017, more than 22 million Americans suffered from sleep apnea and 80% of moderate to severe sleep apnea cases were undiagnosed; worldwide, over 100 million people suffer from sleep apnea. Thus, the increasing incidence of sleep apnea is one of the factors responsible for the growth of the sleep apnea devices market.
It is known that obstructive sleep apnea (OSA) is a prevalent condition, which affects up to 20% of the world population. It is a serious and life-threatening sleep illness that is largely undiagnosed and untreated. However, various government initiatives are helping patients who suffer from OSA. For instance, in the United States, the American Sleep Apnea Association (ASAA) was founded in 1990, which is a non-profit organization that promotes awareness regarding sleep apnea, works for continuing improvements in treatments for this serious disorder, and advocates for the interests of sleep apnea patients. All these factors are boosting the market.
Scope of the Report
Sleep apnea is a serious sleep disorder, in which breathing repeatedly stops and starts. There are three main types of sleep apnea, obstructive sleep apnea, central sleep apnea, and complex sleep apnea syndrome. The factors, such as increased incidences of sleep apnea, increasing awareness among the patient population in the developing countries, favorable government initiatives, and upcoming technological advancements, are expected to drive the growth of the market over the forecast period.
Key Market Trends
Actigraphy Devices is Expected to Grow with Highest CAGR in the Diagnostic Devices Category
Actigraphy devices (actometer or actimeter) utilize a portable device, which is usually worn on the wrist that records physical movement over an extended period. This technology is being increasingly adopted in clinical settings, as actigraphy has the advantage of providing objective information on the sleep habits in patients’ natural sleep environment.
Since actigraphy is less invasive and less expensive than the PSG devices, it is a promising device for assessing sleep apnea treatment effects. It also can be used for follow-up, once the treatment has begun or to evaluate changes in sleep, over the course of the treatment period. The rising demand for actigraphy devices in sleep apnea is due to its cost effectiveness, as it facilitates non-intrusive 24-hours monitoring at home for extended periods. The sleep-wake is relatively easy and it does not require any installation.
North America Dominates the Market and Expected to continue its Dominance through the Forecast Period
North America currently dominates the market for sleep apnea devices and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the high incidence of sleep-disordered breathing (SDB) and rising aging population in the region. The United States holds the majority of the market in the North American region. According to the American Sleep Association, as of 2018, it was estimated that about 50-70 million adult population in the United States were found to have a sleep disorder, 48% were reported to be snoring, 37.9% were reported to be falling asleep during the day, unintentionally, and 4.7% were reported to be nodding off while driving. Insomnia is the most common specific sleep disorder, with short-term issues reported by about 30% of adults and chronic insomnia by 10%. Approximately 25 million adults in the United States have obstructive sleep apnea.
According to Sleep Zone, it was estimated that about 22 million Americans suffer from moderate to severe sleep apnea, out of which, approximately 3-7% of men and 2-5% of women were found to have had sleep apnea in 2018 in the United States.
Competitive Landscape
The sleep apnea devices market is highly competitive and consists of several major player, across the world. Further, with rising technological advancements and product innovations, mid-size and small scale companies are increasing their market presence by introducing new devices into the market with competitive prices. Companies, like Resmed, Fisher & Paykel Healthcare Limited, and Invacare Corporation, hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidences of Sleep Apnea
4.2.2 Increasing Awareness Among the Patient Population in the Developing Countries
4.2.3 Favorable Government Initiatives
4.2.4 Upcoming Technological Advancements
4.3 Market Restraints
4.4 Industry Attractiveness- Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Diagnostic Devices
5.1.1 Polysomnography Devices (PSG)
5.1.2 Pulse Oximeters
5.1.3 Actigraphy Devices
5.2 By Therapeutic Devices
5.2.1 Positive Airway Pressure (PAP) Devices
5.2.1.1 Continuous Positive Airway Pressure (CPAP) Devices
5.2.1.2 Bi-level Positive Airway Pressure (BiPAP) Devices
5.2.2 Oxygen Devices
5.2.2.1 Oxygen Concentrators
5.2.2.2 Portable Oxygen Concentrators
5.2.2.3 Liquid Portable Oxygen
5.2.3 Oral Appliances
5.2.4 Adaptive Servo Ventilation (ASV) Devices
5.2.5 Masks and Accessories
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle East & Africa
5.3.5.1 GCC
5.3.5.2 South Africa
5.3.5.3 Rest of Middle East & Africa
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Fisher & Paykel Healthcare Limited
6.1.2 Koninklijke Philips NV
6.1.3 Invacare Corporation
6.1.4 Natus Medical Incorporated
6.1.5 Resmed
6.1.6 Cadwell Laboratories Inc.
6.1.7 Vyaire Medical Inc.
6.1.8 GE Healthcare
6.1.9 Nihon Kohden Corporation
6.1.10 Teleflex Incorporated
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Diagnostic Devices
Polysomnography Devices (PSG)
Pulse Oximeters
Actigraphy Devices
By Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Continuous Positive Airway Pressure (CPAP) Devices
Bi-level Positive Airway Pressure (BiPAP) Devices
Oxygen Devices
Oxygen Concentrators
Portable Oxygen Concentrators
Liquid Portable Oxygen
Oral Appliances
Adaptive Servo Ventilation (ASV) Devices
Masks and Accessories
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Iron Deficiency Anemia Therapy Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
Iron deficiency anemia is a common condition affecting, especially, children and young women across the world. Iron deficiency is a major problem in developed countries, such as the United States, Canada, the United Kingdom, and across Europe. Moreover, in developing countries, iron deficiency anemia is frequently exacerbated by malaria and other worm infections. The current market is growing, due to the rising incidences of iron deficiency anemia. The increasing risk of hemodilution in pregnant women acts as a major driver for this market. The need to reduce the burden of iron-deficiency anemia has led to an increase in the demand for its treatment, which subsequently drives the global market.
Scope of the Report
This report estimates the global iron deficiency anemia therapy market. It includes a detailed analysis of the various available therapies for treating anemia in healthcare facilities of major geographical regions. Iron deficiency anemia is caused due to the lack of iron and is is one of the most common types of anemia. In case of women, during the child-bearing age, iron loss in the blood will be caused due to heavy menstruation or pregnancy. Certain intestinal diseases and poor diet can also cause anemia.
Key Market Trends
Parenteral Iron Therapy Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Parenteral iron therapy is generally offered to patients who are either unable to absorb oral iron or are still diagnosed with increasing anemia, even after taking adequate doses of oral iron supplements. Many intravenous iron supplementation products are being approved by FDA, which is likely to drive the market in the future. Administration of parenteral iron supplement can lead to adverse effects, such as anaphylaxis, shock, severe hypotension, collapse, and loss of consciousness. Prevalence of anemia cases and patients’ irresponsiveness toward oral and dietary therapies are the factors likely to drive the market over the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the overall iron deficiency anemia therapy market, with the United States being the major contributor to the market. The prevalence of anemia is a significant public health indicator and has remained a relevant health concern in the United States. Since 1990, the prevalence rate of iron deficiency anemia in US infants did not drop, making iron deficiency a significant public health problem in the United States. Hence, the high prevalence rate of anemia is expected to boost the growth of the market in North America.
Competitive Landscape
High sustainable competitive advantage through innovation is also contributing to the increasing competitive rivalry. The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as Allergan, Integra Lifesciences, Galderma Pharma SA, Teoxane, and Sinclair Pharma PLC, among others. The industry is witnessing a series of acquisitions and mergers.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Cases of Haemodilution in Pregnancy
4.2.2 High Prevalence of Anemia
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines
4.3.2 Adverse Effects
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Therapy Type
5.1.1 Oral Iron Therapy
5.1.2 Parenteral Iron Therapy
5.1.3 Red Blood Cell Transfusion
5.1.4 Other Therapy Types
5.2 End User
5.2.1 Hospitals
5.2.2 Clinics
5.2.3 Home Healthcare
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergen
6.1.2 Akebia Therapeutics
6.1.3 AMAG Pharmaceuticals
6.1.4 Keryx Biopharmaceuticals Inc.
6.1.5 Luitpold Pharmaceuticals Inc.
6.1.6 Johnson & Johnson
6.1.7 Pharmacosmos AS
6.1.8 Pieris
6.1.9 Allergen
6.1.10 AMAG Pharmaceuticals
6.1.11 Johnson & Johnson
6.1.12 Pharmacosmos A/S
6.1.13 Pieris
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Therapy Type
Oral Iron Therapy
Parenteral Iron Therapy
Red Blood Cell Transfusion
Other Therapy Types
End User
Hospitals
Clinics
Home Healthcare
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Spinal Surgery Devices Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 10-06-2019
Market Overview
The global spinal surgery devices market was valued at USD 11,553.79 million in 2018, and is estimated to be valued at USD 15,769.46 million in 2024, witnessing a CAGR of 5.30%. The key factors propelling the growth of this market are the increasing adoption rate of minimally invasive spinal surgeries, increasing technological advancements in spinal surgery, and increasing incidences of obesity and degenerative spinal conditions.
As per the report of the National Institute of Health, in 2016, more than 1.9 billion adults were overweight, out of which 650 million were obese. It has also been reported that approximately 39% of adults were overweight and 13% were obese, in 2016. These numbers are further expected to increase with changing lifestyles and food consumption methods in the developed countries. Along with a likely increase in spinal problems in obese populations, owing to increase in obesity, the degenerative spinal conditions are also expected to increase.
According to the American Association of Neurological Surgeons, more than 65 million Americans suffer from lower back pain, annually, while according to the Chicago Institute of Neurosurgery and Neuroresearch, by the age of fifty, 85% of the population is likely to show evidence of disc degeneration. So, with the growing geriatric population, the number of people suffering from lower back pain and other degenerative spinal conditions is expected to increase during the forecast period.
Scope of the Report
As per the scope of the report, the spinal surgery devices market is a significant, money-spinning sub-segment of the orthopaedic industry. Spine surgery has traditionally been an open surgery’, wherein, a long incision allows the surgeon to access the spine anatomy.
Key Market Trends
Spinal Fusion is Expected to hold its Highest Market Share in the Device Type Segment
In the device type segment of the spinal surgery devices market, spinal fusion is believed to have the largest market size and is expected to witness a CAGR of 5.05%, during the forecast period.
The spinal fusion device type is sub-segmented into instrumented and non-instrumented spinal fusion, cervical fusion, interbody fusion, and lumbar fusion. Many products in the market provide conventional, yet effective treatments to patients suffering from lumbar spinal stenosis, along with alternative advanced treatments for decompression spine surgery. The major market players manufacture both anterior and posterior dynamic stabilization devices for the lumbar spine. Moreover, many clinical trials are in the process for further development. This factor is likely to offer various benefits to the market studied. A major share of the market studied is occupied by posterior screw fusion systems, due to their increased usage. The share of the same is expected to increase over the forecast period, registering a healthy CAGR.
North America Dominates the Market and Expected to do the Same during the Forecast Period
North America currently dominates the market for spinal surgery devices and is expected to continue its stronghold for a few more years. The United States holds the largest share of the market. According to a survey conducted in the United States, by the National Centre for Health Statistics, more than 65 million Americans suffer from lower back problems, every year. Moreover, in terms of surgery type, spinal fusion has a higher risk of infection and readmission to the hospital, and there is no evidence that it provides greater benefit to patients. However, its use increased by 67% among Medicare patients and is now more common than spinal decompression.
The US segment of the market studied is expected to grow, due to a general shift in the trend toward more minimally invasive surgeries in the spinal implant market, over the forecast period.
Competitive Landscape
The spinal surgery sevices market is moderately competitive and consists of several major players. Moreover, with increasing technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with better usability. Companies, like Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic, and Globus Medical Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.2.2 Increasing Number of Technological Advances in Spinal Surgery
4.2.3 Increasing Incidences of Obesity and Degenerative Spinal Conditions
4.3 Market Restraints
4.3.1 Stringent Regulatory Process For New Product Approval
4.3.2 Expensive Treatment Procedures
4.3.3 Stringent Reimbursement Concerns
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Spinal Decompression
5.1.1.1 Corpectomy
5.1.1.2 Discectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Device Type
Spinal Decompression
Corpectomy
Discectomy
Facetectomy
Foraminotomy
Laminotomy
Spinal Fusion
Instrumented And Non-Instrumented Spinal Fusion
Cervical Fusion
Interbody Fusion
Lumbar Fusion
Fracture Repair Devices
Arthroplasty Devices
Non-fusion Devices
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Market Overview
The global spinal surgery devices market was valued at USD 11,553.79 million in 2018, and is estimated to be valued at USD 15,769.46 million in 2024, witnessing a CAGR of 5.30%. The key factors propelling the growth of this market are the increasing adoption rate of minimally invasive spinal surgeries, increasing technological advancements in spinal surgery, and increasing incidences of obesity and degenerative spinal conditions.
As per the report of the National Institute of Health, in 2016, more than 1.9 billion adults were overweight, out of which 650 million were obese. It has also been reported that approximately 39% of adults were overweight and 13% were obese, in 2016. These numbers are further expected to increase with changing lifestyles and food consumption methods in the developed countries. Along with a likely increase in spinal problems in obese populations, owing to increase in obesity, the degenerative spinal conditions are also expected to increase.
According to the American Association of Neurological Surgeons, more than 65 million Americans suffer from lower back pain, annually, while according to the Chicago Institute of Neurosurgery and Neuroresearch, by the age of fifty, 85% of the population is likely to show evidence of disc degeneration. So, with the growing geriatric population, the number of people suffering from lower back pain and other degenerative spinal conditions is expected to increase during the forecast period.
Scope of the Report
As per the scope of the report, the spinal surgery devices market is a significant, money-spinning sub-segment of the orthopaedic industry. Spine surgery has traditionally been an open surgery’, wherein, a long incision allows the surgeon to access the spine anatomy.
Key Market Trends
Spinal Fusion is Expected to hold its Highest Market Share in the Device Type Segment
In the device type segment of the spinal surgery devices market, spinal fusion is believed to have the largest market size and is expected to witness a CAGR of 5.05%, during the forecast period.
The spinal fusion device type is sub-segmented into instrumented and non-instrumented spinal fusion, cervical fusion, interbody fusion, and lumbar fusion. Many products in the market provide conventional, yet effective treatments to patients suffering from lumbar spinal stenosis, along with alternative advanced treatments for decompression spine surgery. The major market players manufacture both anterior and posterior dynamic stabilization devices for the lumbar spine. Moreover, many clinical trials are in the process for further development. This factor is likely to offer various benefits to the market studied. A major share of the market studied is occupied by posterior screw fusion systems, due to their increased usage. The share of the same is expected to increase over the forecast period, registering a healthy CAGR.
North America Dominates the Market and Expected to do the Same during the Forecast Period
North America currently dominates the market for spinal surgery devices and is expected to continue its stronghold for a few more years. The United States holds the largest share of the market. According to a survey conducted in the United States, by the National Centre for Health Statistics, more than 65 million Americans suffer from lower back problems, every year. Moreover, in terms of surgery type, spinal fusion has a higher risk of infection and readmission to the hospital, and there is no evidence that it provides greater benefit to patients. However, its use increased by 67% among Medicare patients and is now more common than spinal decompression.
The US segment of the market studied is expected to grow, due to a general shift in the trend toward more minimally invasive surgeries in the spinal implant market, over the forecast period.
Competitive Landscape
The spinal surgery sevices market is moderately competitive and consists of several major players. Moreover, with increasing technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with better usability. Companies, like Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic, and Globus Medical Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.2.2 Increasing Number of Technological Advances in Spinal Surgery
4.2.3 Increasing Incidences of Obesity and Degenerative Spinal Conditions
4.3 Market Restraints
4.3.1 Stringent Regulatory Process For New Product Approval
4.3.2 Expensive Treatment Procedures
4.3.3 Stringent Reimbursement Concerns
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Spinal Decompression
5.1.1.1 Corpectomy
5.1.1.2 Discectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Device Type
Spinal Decompression
Corpectomy
iscectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Market Overview
The global spinal surgery devices market was valued at USD 11,553.79 million in 2018, and is estimated to be valued at USD 15,769.46 million in 2024, witnessing a CAGR of 5.30%. The key factors propelling the growth of this market are the increasing adoption rate of minimally invasive spinal surgeries, increasing technological advancements in spinal surgery, and increasing incidences of obesity and degenerative spinal conditions.
As per the report of the National Institute of Health, in 2016, more than 1.9 billion adults were overweight, out of which 650 million were obese. It has also been reported that approximately 39% of adults were overweight and 13% were obese, in 2016. These numbers are further expected to increase with changing lifestyles and food consumption methods in the developed countries. Along with a likely increase in spinal problems in obese populations, owing to increase in obesity, the degenerative spinal conditions are also expected to increase.
According to the American Association of Neurological Surgeons, more than 65 million Americans suffer from lower back pain, annually, while according to the Chicago Institute of Neurosurgery and Neuroresearch, by the age of fifty, 85% of the population is likely to show evidence of disc degeneration. So, with the growing geriatric population, the number of people suffering from lower back pain and other degenerative spinal conditions is expected to increase during the forecast period.
Scope of the Report
As per the scope of the report, the spinal surgery devices market is a significant, money-spinning sub-segment of the orthopaedic industry. Spine surgery has traditionally been an open surgery’, wherein, a long incision allows the surgeon to access the spine anatomy.
Key Market Trends
Spinal Fusion is Expected to hold its Highest Market Share in the Device Type Segment
In the device type segment of the spinal surgery devices market, spinal fusion is believed to have the largest market size and is expected to witness a CAGR of 5.05%, during the forecast period.
The spinal fusion device type is sub-segmented into instrumented and non-instrumented spinal fusion, cervical fusion, interbody fusion, and lumbar fusion. Many products in the market provide conventional, yet effective treatments to patients suffering from lumbar spinal stenosis, along with alternative advanced treatments for decompression spine surgery. The major market players manufacture both anterior and posterior dynamic stabilization devices for the lumbar spine. Moreover, many clinical trials are in the process for further development. This factor is likely to offer various benefits to the market studied. A major share of the market studied is occupied by posterior screw fusion systems, due to their increased usage. The share of the same is expected to increase over the forecast period, registering a healthy CAGR.
North America Dominates the Market and Expected to do the Same during the Forecast Period
North America currently dominates the market for spinal surgery devices and is expected to continue its stronghold for a few more years. The United States holds the largest share of the market. According to a survey conducted in the United States, by the National Centre for Health Statistics, more than 65 million Americans suffer from lower back problems, every year. Moreover, in terms of surgery type, spinal fusion has a higher risk of infection and readmission to the hospital, and there is no evidence that it provides greater benefit to patients. However, its use increased by 67% among Medicare patients and is now more common than spinal decompression.
The US segment of the market studied is expected to grow, due to a general shift in the trend toward more minimally invasive surgeries in the spinal implant market, over the forecast period.
Competitive Landscape
The spinal surgery sevices market is moderately competitive and consists of several major players. Moreover, with increasing technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new technologies with better usability. Companies, like Zimmer Biomet, Stryker Corporation, Depuy Synthes, Medtronic, and Globus Medical Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.2.2 Increasing Number of Technological Advances in Spinal Surgery
4.2.3 Increasing Incidences of Obesity and Degenerative Spinal Conditions
4.3 Market Restraints
4.3.1 Stringent Regulatory Process For New Product Approval
4.3.2 Expensive Treatment Procedures
4.3.3 Stringent Reimbursement Concerns
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Device Type
5.1.1 Spinal Decompression
5.1.1.1 Corpectomy
5.1.1.2 Discectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Device Type
Spinal Decompression
Corpectomy
iscectomy
5.1.1.3 Facetectomy
5.1.1.4 Foraminotomy
5.1.1.5 Laminotomy
5.1.2 Spinal Fusion
5.1.2.1 Instrumented And Non-Instrumented Spinal Fusion
5.1.2.2 Cervical Fusion
5.1.2.3 Interbody Fusion
5.1.2.4 Lumbar Fusion
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Alphatec Spine Inc.
6.1.6 Seaspine
6.1.7 Zimmer Holdings Inc.
6.1.8 SpineGuard SA
6.1.9 K2M Group Holdings Inc.
6.1.10 Nuvasive Inc.
6.1.11 Joimax GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Cancer Therapy Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 117 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 117 pages
- Published: 07-06-2019
Market Overview
The global cancer therapy market was valued at USD 136,254.35 million in 2018, and is estimated to be valued at USD 220,701.26 million in 2024, witnessing a CAGR of 8.37%. Certain factors that are driving the market growth include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players.
More than 45 million Americans do not have health insurance and millions more are underinsured; eight out of 10 uninsured people are from working families. Among those with health insurance, one out of 10 individuals, 65 years old or younger, and one in three persons over 65 years do not have prescription drug coverage. Hence, Patients Assistance Programs (PAPs) have emerged in an effort to help patients who are lacking health insurance or prescription drug coverage get the medication they need. These programs are provided by pharmaceutical companies to provide free or low-cost prescription drugs to patients who are suffering from serious illnesses.
Several big pharmaceutical companies, such as Pfizer and Eli lily, have also started these programs to help uninsured patients who are suffering from chronic diseases. Thus, a large number of uninsured patients, suffering from cancer, can also undergo cancer therapies, which is likely to augment the growth of the market.
Scope of the Report
As per the scope of the report, cancer therapies are drugs that block the growth and proliferation of cancer, by interfering with specific molecules, such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. These therapies include surgery, radiation therapy, chemotherapy, immunotherapy, etc.
Key Market Trends
The Target Therapy Segment is Expected to show the Fastest Growth in the Forecast Period
The target therapy segment is expected to show the highest CAGR of 9.68% during the forecast period. The target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. Targeted therapy is attaining importance due to its specificity toward cancer cells, while sparing the toxicity to off-target cells.
The breast cancer segment is belived to account for the largest market size over the forecast period. This is majorly attrobuted to the higher and continuously increaisng prevalence of breast cancer acoss the world. As per estimates provided by the Breast Cancer Organization in 2018, it is estimated that over 2,66,120 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 63,960 new cases of non-invasive (in situ) breast cancer.
North America Currently Dominates the Cancer Therapy Market and is Expected to Continue in the Forecast Period
North America currently dominates the market for cancer therapy and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased adoption of cancer therapy. The United States holds majority of the market in the North American region, due to the rising prevalence of cancer in the country. According to the National Cancer Institute (NCI), in 2016, 1.6 million people suffered from cancer, and around 0.5 million people died from cancer. This figure indicates that the prevalence of cancer is rapidly increasing in the United States.
Competitive Landscape
The cancer therapy market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence, by introducing new products with cheaper prices. Companies, like Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, and Johnson and Johnson, hold significant shares in the cancer therapy market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Patient Assistance Programs (PAPs)
4.2.2 Growing Government Initiatives for Cancer Awareness
4.2.3 Rising Prevalence of Cancer Worldwide
4.2.4 Strong R&D Initiatives from Key Players
4.3 Market Restraints
4.3.1 Fluctuation in Reimbursement Policies
4.3.2 High Cost of Cancer Therapies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Treatment Type
5.1.1 Chemotherapy
5.1.2 Targeted Therapy
5.1.3 Immunotherapy
5.1.4 Hormonal Therapy
5.1.5 Other Treatment Types
5.2 By Cancer Type
5.2.1 Blood Cancer
5.2.2 Breast Cancer
5.2.3 Prostate Cancer
5.2.4 Gastrointestinal Cancer
5.2.5 Gynecologic Cancer
5.2.6 Respiratory/Lung Cancer
5.2.7 Other Cancer Types
5.3 By End User
5.3.1 Hospitals
5.3.2 Spcialty Clinics
5.3.3 Cancer and Radiation Therapy Centers
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 South Korea
5.4.3.5 Australia
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Amgen Inc.
6.1.2 AstraZeneca PLC
6.1.3 Bayer AG
6.1.4 Johnson and Johnson
6.1.5 Merck & Co. Inc.
6.1.6 F. Hoffmann-La Roche AG
6.1.7 Eli Lilly and Company
6.1.8 Novartis AG
6.1.9 Pfizer Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Treatment Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Other Treatment Types
By Cancer Type
Blood Cancer
Breast Cancer
Prostate Cancer
Gastrointestinal Cancer
Gynecologic Cancer
Respiratory/Lung Cancer
Other Cancer Types
By End User
Hospitals
Spcialty Clinics
Cancer and Radiation Therapy Centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Infectious Wound Care Management Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 117 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 117 pages
- Published: 07-06-2019
Market Overview
The growth of the market studied can be attributed to the increasing global geriatric population. As the population is increasing, age-related diseases are on the rise, thereby bolstering the demand for wound care management products. The current market is also growing due to the increasing prevalence of diabetes and rise in number of the accidents and burns. These factors are fueling the growth of the market studied. Due to the product innovations in the recent years, the market studied has been growing profitably worldwide.
Scope of the Report
The global infectious wound care management market (henceforth referred to as the market studied) involves the various products that help in healing and preventing infections. Wound care and closure and advanced wound care and closure products are used to treat acute and chronic wounds. Wound therapies have steadily advanced, to treat the patients more effectively and comprehensively. Over the next few years, the demand for wound care products is expected to increase significantly, particularly in the emerging economies.
Key Market Trends
Diabetes Mellitus Segment is Expected to exhibit Fastest Growth Rate Over the Forecast Period
Diabetic wounds are of three types: neuropathic, ischemic, and neuroischemic. Knowing the distinct features of each wound category is essential for identifying wound progression, infection, and healing. Failure in properly identifying the type of wound can lead to an ineffective diabetic wound treatment plan, causing long-term complications or amputation.
Infections are the main concern in any diabetic wound treatment plan. Due to the high morbidity and mortality rates associated with diabetic wounds, more aggressive forms of infection control are necessary. Both oral and topical antibiotics are recommended for all diabetic wound treatment patients who indicate signs of infection. A diabetes wound patient must be treated holistically, to reduce the risk factors that cause wounds. Achieving control over diabetes is difficult but essential, especially in terms of blood glucose levels, proper nutrition, high blood pressure, and smoking cessation.
North America captured the Largest Market Share and is expected to retain its Dominance
North America dominated the overall Infectious wound care management market, with the United States accounting for the major contribution to the same. The US segment of the market studied is the most progressive and lucrative in the world, with unconventional practices, products, and world-class clinicians.
According to the National Institutes of Health, human skin wound is a significant indirect threat to the US economy, as the government takes responsibility for the treatment of the public. This has prompted the government to invest significant amounts of money toward developing effective treatment methods. Research in the United States has revealed that the incidence of non-healing cutaneous wounds is about USD 5-7 million per year, in the country. The relative expenditure for these wounds is about USD 25 billion.
Competitive Landscape
Competition among the existing players is high and price pressure has been increasing among the vendors. Despite the high number of market participants, the majority of the market share is controlled by a handful of participants. The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as Bristol-Myers Squibb Company, Cardinal Health Inc., Sanofi, Smith & Nephew, and 3M, among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Diabetes
4.2.2 Rising Aging Population
4.2.3 Increasing Number of Accidents and Burn Cases
4.3 Market Restraints
4.3.1 Risks Associated with Improper Usage and Application of Wound Care Products
4.3.2 Side Effects of Antibiotics
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product Type
5.1.1 Therapy
5.1.1.1 Antibiotic Therapy
5.1.1.2 Iodine Therapy
5.1.1.3 Silver Therapy
5.1.1.4 Other Therapies
5.1.2 Device
5.1.2.1 Wound Dressing
5.1.2.1.1 Film Dressing
5.1.2.1.2 Silver Dressing
5.1.2.1.3 Alginate Dressing
5.1.2.1.4 Other Devices
5.1.2.2 Compression Bandage
5.1.2.3 Negative Pressure Wound Therapy
5.2 Type of Wound
5.2.1 Diabetes Mellitus
5.2.2 Autoimmune Disorder
5.2.3 Hypoxia/Poor Tissue Perfusion
5.2.4 Other Types of Wound
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bristol-Myers Squibb Company
6.1.2 Cardinal Health Inc.
6.1.3 Sanofi
6.1.4 Smith & Nephew
6.1.5 Molnlycke Health Care AB
6.1.6 3M
6.1.7 Kinetics Concept Company
6.1.8 Coloplast Group
6.1.9 Convatec Group PLC
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Product Type
Therapy
Antibiotic Therapy
Iodine Therapy
Silver Therapy
Other Therapies
Device
Wound Dressing
Film Dressing
Silver Dressing
Alginate Dressing
Other Devices
Compression Bandage
Negative Pressure Wound Therapy
Type of Wound
Diabetes Mellitus
Autoimmune Disorder
Hypoxia/Poor Tissue Perfusion
Other Types of Wound
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
North-America Genetic Testing Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 75 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 75 pages
- Published: 10-06-2019
Market Overview
The major factors, such as emphasis on early disease detection and prevention, growing demand for personalized medicine, increasing application of genetic testing in oncology, and large demand for direct-to-customer genetic tests are expected to drive the growth of the overall market.
There are also many genetic disorders that are being detected early during pregnancy, using various invasive and non-invasive techniques. With these technological developments, physicians have become capable of performing tests with better accuracy and looking at multiple genes at a time. Consumer demand for safe and effective genetic tests is fueling the growth of this market. Additionally, growing demand for personalized medicine and increasing application of genetic testing in oncology are also resulting in the growth of the North American genetic testing market.
There is also an increase in awareness among the individuals about the benefits and the potentiality of genetic testing to identify and cure diseases or abnormalities, which is the main reason for the growth genetic testing market.
In addition, increase in aging population, advancements of technology in the genetic testing space, subsequent increase in the cases of chronic diseases, and rising cancer case incidences are the few other factors aiding the growth of the North American genetic testing market.
Scope of the Report
As per the scope of this report, a genetic test is performed to identify the presence of a gene with a particular sequence in the genome. The gene can be either identified directly through sequencing or it can be identified indirectly through various methods. These genetic tests are carried out to assess the risk of an individual developing a certain disease.
Key Market Trends
Predictive and Presymptomatic Testing is the Largest Segment by Type that is Expected to Grow During the Forecast Period
Predictive and pre-symptomatic testing is utilized for the detection of gene mutations that are related to disorders appearing after birth, frequently in later stages of life. Such tests can be of assistance to individuals having a family member with a genetic disorder, though they are free from any features of the disorder while testing. Predictive testing can aid in the identification of mutations that can increase an individual’s possibilities of developing disorders, as in the case of specific cancers.
Thus the rising incidences of cancer and growing awareness about the diseases are expected to lead to more such tests, which in turn, is expected to drive the market.
Competitive Landscape
Growing genetic disease incidences unravel new opportunities for genetic testing and its related applications. The transformation of genetic testing from being a service-driven market to a product-driven market is anticipated to provide a push to the diagnostic companies for the expansion of their operations.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Emphasis on Early Disease Detection and Prevention
4.2.2 Growing Demand for Personalized Medicine
4.2.3 Increasing Application of Genetic Testing in Oncology
4.2.4 Large Demand for Direct-to-customer Genetic Tests
4.3 Market Restraints
4.3.1 High Costs of Genetic Testing
4.3.2 Potentially Adverse Personal or Societal Consequences
4.3.3 FDA Strictly Regulates Laboratory Developed Tests (LDTs)
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Carrier Testing
5.1.2 Diagnostic Testing
5.1.3 Newborn Screening
5.1.4 Predictive and Presymptomatic Testing
5.1.5 Prenatal Testing
5.1.6 Other Types
5.2 By Diseases
5.2.1 Alzheimer’s Diseases
5.2.2 Cancer
5.2.3 Cystic Fibrosis
5.2.4 Sickle Cell Anemia
5.2.5 Duchenne Muscular Dystrophy
5.2.6 Thalassemias
5.2.7 Huntington’s Disease
5.2.8 Special Diseases
5.2.9 Other Diseases
5.3 By Technology
5.3.1 Cytogenetic Testing
5.3.2 Biochemical Testing
5.3.3 Molecular Testing
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 23&Me Inc.
6.1.2 Abbott Laboratories
6.1.3 Ariosa Diagnostics Inc.
6.1.4 Cepheid Inc.
6.1.5 Illumina Inc.
6.1.6 Luminex Corporation
6.1.7 Biorad Laboratories Inc.
6.1.8 PerkinElmer Inc.
6.1.9 Quest Diagnostics Incorporated
6.1.10 F. Hoffmann-La Roche Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Carrier Testing
Diagnostic Testing
Newborn Screening
Predictive and Presymptomatic Testing
Prenatal Testing
Other Types
By Diseases
Alzheimer’s Diseases
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemias
Huntington’s Disease
Special Diseases
Other Diseases
By Technology
Cytogenetic Testing
Biochemical Testing
Molecular Testing
Geography
North America
United States
Canada
Mexico